A client has been newly diagnosed with rheumatoid arthritis. The nurse recognizes that the healthcare provider will most likely order which drug classification as the first choice for treatment?

Choice A rationale Opioids are typically reserved for severe, chronic pain that does not respond to other therapies and are not considered first-line treatment for rheumatoid arthritis. They provide analgesia but do not address the underlying inflammatory processes or provide the anti-inflammatory benefits necessary to manage joint swelling and prevent damage. Furthermore, the risk for dependence and respiratory depression makes them less ideal for initial management. Choice B rationale Acetaminophen is an effective analgesic for mild to moderate pain, but it lacks significant anti-inflammatory properties. Because rheumatoid arthritis is a chronic systemic inflammatory disease characterized by synovitis and joint destruction, acetaminophen alone is insufficient for primary treatment. It might be used as an adjunct for pain control, but it cannot replace medications that actively target the inflammatory response occurring within the joints. Choice C rationale Nonsteroidal anti-inflammatory drugs are the first-line choice for managing the immediate symptoms of rheumatoid arthritis, such as pain and inflammation. They work by inhibiting cyclooxygenase enzymes, which reduces the production of prostaglandins that mediate the inflammatory response. While they do not slow the progression of the disease like DMARDs, they are essential for providing rapid symptomatic relief during the initial diagnostic and treatment phases. Choice D rationale Hormone replacement therapy is used to manage symptoms related to hormonal deficiencies, such as those occurring during menopause, and has no established role as a primary treatment for rheumatoid arthritis. While hormonal shifts can sometimes influence autoimmune conditions, HRT does not provide the analgesic or anti-inflammatory effects required to manage the joint inflammation and pain that characterize a new diagnosis of rheumatoid arthritis.